Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ReposiTrak | TRAK | Oct 31, 2024 | 19.25 | -2.04 |
Republic Bancorp A | RBCAA | Oct 31, 2024 | 67.50 | -2.02 |
Republic Services | RSG | Oct 31, 2024 | 198.00 | -0.41 |
Research Frontiers | REFR | Oct 31, 2024 | 2.20 | +1.85 |
Research Solutions | RSSS | Oct 31, 2024 | 2.63 | +0.38 |
Reservoir Media | RSVR | Oct 31, 2024 | 8.33 | -3.81 |
ReShape Lifesciences | RSLS | Oct 31, 2024 | 5.65 | +3.67 |
Resideo Technologies | REZI | Oct 31, 2024 | 19.67 | -2.62 |
ResMed | RMD | Oct 31, 2024 | 242.47 | -0.23 |
Resources Connection | RGP | Oct 31, 2024 | 8.05 | -3.01 |
Restaurant Brands International | QSR | Oct 31, 2024 | 69.55 | -0.80 |
Retail Bull 3X Direxion | RETL | Oct 31, 2024 | 8.39 | -2.21 |
Retail ETF Market Vectors | RTH | Oct 31, 2024 | 213.99 | -0.76 |
Retail Opportunity Investments | ROIC | Oct 31, 2024 | 15.50 | -0.32 |
ReTo Eco-Solutions | RETO | Oct 31, 2024 | 1.13 | -2.59 |
Retractable Technologies | RVP | Oct 31, 2024 | 0.72 | +1.08 |
REV Group | REVG | Oct 31, 2024 | 26.50 | -1.05 |
Revance Therapeutics | RVNC | Oct 31, 2024 | 5.90 | -0.34 |
Revelation Biosciences | REVB | Oct 31, 2024 | 0.85 | -0.24 |
Revenueshares Largecap | RWL | Oct 31, 2024 | 97.11 | -0.64 |
Revenueshares Midcap | RWK | Oct 31, 2024 | 115.20 | -1.38 |
Revenueshares Smallcap | RWJ | Oct 31, 2024 | 44.20 | -1.62 |
Revenueshares Ultra Dividend Fund | RDIV | Oct 31, 2024 | 49.89 | +0.06 |
Reviva Pharmaceuticals | RVPH | Oct 31, 2024 | 1.12 | -3.03 |
Revolution Medicines | RVMD | Oct 31, 2024 | 53.50 | +5.94 |
Revolve Group A | RVLV | Oct 31, 2024 | 24.82 | -1.94 |
Revvity | RVTY | Oct 31, 2024 | 118.59 | -1.20 |
REX American Resources | REX | Oct 31, 2024 | 44.73 | -0.40 |
Rexford Industrial Realty | REXR | Oct 31, 2024 | 42.89 | -2.59 |
Rexford Industrial Realty B Pref | REXR-B | Oct 31, 2024 | 22.99 | +0.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.